Neoton and thrombolytic therapy in myocardial infarction

Terapevticheskii Arkhiv

Volumn 73, Issue 9, 2001, Pages 50-55

  Perepech, M B ^a   Nedoshivin, A O ^a   Nersterova, I V ^a  

^a NONE

Author keywords

Arrhythmias; Left ventricular dilation; Myocardial infarction; Neoton; Thrombolytic therapy

Indexed keywords

CREATINE PHOSPHATE; STREPTOKINASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FIBRINOLYTIC THERAPY; HEART ARRHYTHMIA; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SYSTOLE;

ADULT; AGED; ARRHYTHMIA; DRUG THERAPY, COMBINATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHOSPHOCREATINE; STREPTOKINASE; SYSTOLE; THROMBOLYTIC THERAPY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0035232581     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarcto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-402.
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet Ibid. 1988; 2: 349-360.
3. Smalling R. W., Fuentes F., Matthews M. W. et al. Factors affecting outcome of coronary reperfusion with intracoronary streptokinase in acute myocardial infarction. Am. J. Cardiol. 1987; 59 (6): 505-512.
4. Hillis W. S., Chamberlain D. A., de Bono D. P. et al. Intravenous anistreplase in acute myocardial infarction: continued reduction in mortality up to 5 years: long-term results of the AIMS study. Eur. Heart J. 1992; 13 (abstr. suppl.): 305.
5. Murohara Y., Yui Y., Hattori R. et al. Effects of Superoxide dismutase on reperfusion arrhythmies and left ventricular function in patients undergains thrombolysis for anterior wall acute myocardial infarction. Am. J. Cardiol. 1991; 67: 765-767.
6. The EMIP-FR Group. Effect of 48-h trimetazidine on shortand long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy, A double-blind, placebo-controlled, randomised trial. Eur. Heart J. 2000; 21: 1537-1546.
7. Saks V. A., Javadov S. A., Pozin E. P. et al. Biochemical basis of the protective action of phosphocreatine on the ischemic myocardium. In: Saks V. A., Bobkov Y. G., Strumia E., eds. Creatine phosphate: biochemistry, pharmacology and clinical efficiency. Torino; 1987. 95-111.
8. Sharov V. G., Saks V. A., Kupriyanov V. V. et al. Protection of ischemic myocardium by exogenous phosphocreatine I. Morphological and phosphorus 31-nuclear magnetic resonance studies. J. Tnorac. Cardiovasc. Surg. 1987; 94: 749-761.
9. Scattolini G., Gambino A., Bellotto F. et al. Phosphocreatine in acute myocardial infarction. In: Saks V. A., Bobkov Y., Strumia E., eds. Creatine phosphate: biochemistry, pharmacology and clinical efficiency. Torino; 1987. 199-205.
10. Ruda M. Ya., Samarenko M. B., Afonskaya N. I. et al. Clinical trial of phosphocreatine in patients with acute myocardial infarction. Creatine Phosphate: Biochemistry, Pharmacology and Clinical Efficiency Ibid. 187-198.
11. Coraggio F., Catalano A., Angiulli B. et al. Analisi dell'evolutione della lesione ischemica da infarto miocardico acuto trattato con fosfocreatina. In: Tronconi L., Saks V. A., eds. International meeting oh phosphocreatine in cardiology and cardiac surgery. Pavia; 1989. 155-162.
12. Steja M., Zeman K., Groch L. et al. The effect of creatine phosphate (Neoton) in acute myocardial infarct (a prospective multicenter pilot study). Vnitr. Lek. 1993; 39: 136-142.
13. Golikov A. P., Ryabinin V. A., Pavlov V. A. et al. Clinical and haemodynamic effects of phosphocreatine in patients with complicated myocardial infarction. In: Saks V. A., Bobkov Y. G., Strumia E., eds. Creatine phosphate: biochemistry, pharmacology and clinical efficiency. Torino; 1987. 206-215.
14. Ryabinin V. A., Golikov A. P., Saks V. A. et al. Significance of phosphocreatine for profilaxys of terminal complication in acute myocardial infarction. In: Tronconi L., Saks V. A., eds. International meeting on phosphocreatine in cardiology and cardiac surgery. Pavia; 1989. 163-170.
15. Samarenko M. B., Ruda M. Ya., Afonskaya N. I. et al. Clinical trial of phosphocreatine in patients with acute myocardial infarction: effects on ischemic and reperfusion induced arrhythmias. International Meeting on Phosphocreatine in Cardiology and Cardiac Surgery Ibid. 149-154.
16. Tomaczewski A., Markiewicz M., Dabrowski P. et al. Evaluation of arrhythmia in patients with acute myocardial infarction receiving neoton. Wiad. Lek. 1994; 47: 570-573.
17. Pfeffer J. M. Progressive ventricular dilation in experimental myocardial infarction and its attenuation by angiotensin-converting enzyme inhibition. Am. J. Cardiol. 1991; 68 (1): 17D-25D.
18. White H. D., Norris R. M., Brown M. A. et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from the myocardial infarction. Circulation 1987; 76: 44-51.
19. Valentine R. P., Pitts D. E., Brooks-Brun J. A. et al. Effects of thrombolysis (streptokinase) on left ventricular function during acute myocardial infarction. Am. J. Cardiol. 1986; 58: 896-899.
20. Timmis G. C., Westveer D. C., Hauser A. M. et al. The influence of infarction site and size on the ventricular response to coronary thrombolysis. Arch. Intern. Med. 1985; 145 (12): 2188-2193.
21. Meinertz T., Kasper W., Schumacher M., Just H. The german multicentral trial plasminogen streptokinase activator complex versus heparin for acute myocardial infarction. Am. J. Cardiol. 1988; 62 (7): 347-351.
22. Ronca G., Ronca-Testoni S., Conte A. et al. Creatine phosphate and protection from peroxidative damage. In: Tronconi L., Saks V. A., eds. Cardioprotection with phosphocreatine in cardiology and cardiac surgery. Pavia; 1989. 61-71.
23. Raisaro A., Bargiggia G. S., Bertucci C. et al. Clinical evaluation of phosphocreatine effect during acute myocardial infarction: a multicenter study. In: Tronconi L., Sate V. A., eds. International meeting on phosphocreatine in cardiology and cardiac surgery. Pavia; 1989. 139-148.